BioBAT Brings Bioscience Research To Brooklyn, New York
05/24/2010
"With the development of BioBAT, together with the East River Science Park set to open this fall, we are building 10 times the amount of commercial lab space that's currently available," said New York City Mayor Michael R. Bloomberg.
The City invested $12 million in the project, and the state offered $48 million of funding. Some organizations, such as the International AIDS Vaccine Initiative, are already located there, and will be joined by several others.
"BioBAT's laboratory, office, and manufacturing space on the Brooklyn waterfront is designed for larger companies and offers affordable rents, convenient transportation, and access to all the leading academic research centers in the city," said SUNY Downstate President John C. LaRosa.
The Brooklyn Army Terminal is a 97-acre facility owned by the city and managed by the New York City Economic Development Corporation. BioBAT is a nonprofit corporation that was created to encourage the development of commercial bioscience research, development, and manufacturing in Brooklyn. The architecture firm HOK will design the facility.
Project Announcements
Sesajal Plans Temple, Texas, Warehousing-Production Operations
04/15/2026
Hitachi Energy Plans Cary, North Carolina, Operations
04/15/2026
Mercedes-Benz Expands Tuscaloosa County, Alabama, Production Operations
04/14/2026
Qblox Plans Canton, Massachusetts, Operations
04/14/2026
Lumentum Holdings Plans Greensboro, North Carolina, Production Operations
04/14/2026
Mars Snacking Expands Chicago, Illinois, Headquarters Operations
04/14/2026
Most Read
-
Economic Developer Role Shifting from Deal-Making to Systems Stewardship
Q1 2026
-
What Companies Need from Modern Manufacturing Sites
Q1 2026
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Capitalizing on the OBBBA Before the 2026 Cliff
Q1 2026
-
Last Word: Don’t Lose by Winning
Q1 2026
-
Advanced Manufacturing Isn’t a Buzzword—It’s a Different Location Strategy
Q1 2026
-
40th Annual Corporate and 22nd Annual Consultant Site Selection Survey Results
Q1 2026